GENEVA, July 31 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. filed a patent application (CN2026/073945) for “PHARMACEUTICAL COMBINATION OF PARP1 INHIBITOR IN COMBINATION WITH RDC AND USE THEREOF IN TREATING TUMOR”. With publication no. WO/2026/158374, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 51/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....